Blog

[:content [\T \h \e \space \D \U \S \C \space \n \o \w \space \p \u \b \l \i \s \h \e \s \space \a \n \space \o \u \t \c \o \m \e \space \s \t \a \t \e \m \e \n \t \space \f \o \l \l \o \w \i \n \g \space \e \a \c \h \space \m \e \e \t \i \n \g \. \space \  \D \U \S \C \space \m \e \e \t \s \space \t \h \r \e \e \space \t \i \m \e \space \a \space \y \e \a \r \space \( \F \e \b \r \u \a \r \y \, \space \J \u \n \e \space \a \n \d \space \O \c \t \o \b \e \r \) \. \  \T \h \e \s \e " ..."]]

[:content [\A \space \n \e \w \space \f \a \c \e \t \space \h \a \s \space \b \e \e \n \space \a \d \d \e \d \space \t \o \space \M \A \E \S \T \r \O \space \A \u \s \t \r \a \l \i \a \space \- \space \s \u \b \m \i \s \s \i \o \n \s \space \f \o \r \space \m \e \d \i \c \i \n \e \s \  \a \s \s \o \c \i \a \t \e \d \space \w \i \t \h \space \a \space \r \i \s \k \- \s \h \a \r \i \n \g \space \a \g \r \e \e \m \e \n \t \space \( \R \S \A \) \. \space \  \A \space \R \S \A " ..."]]

Under the Australian Government’s National Medicines Policy framework, the Department of Health is conducting a Post-market Review of Authority Required ...

The National Health Act (1953) has recently been amended to implement measures announced as part of the PBS Access and Sustainability ...

The Generic Medicines Industry Association (GMiA) welcomes the decision of the Pharmaceutical Benefits Advisory Committee (PBAC) to consider “a” flagging ...

[:content [\1 \7 \space \M \a \r \c \h \space \2 \0 \1 \4 \space \- \space \t \h \e \space \P \B \A \C \space \c \o \n \s \i \d \e \r \e \d \space \a \space \m \a \j \o \r \space \s \u \b \m \i \s \s \i \o \n \space \f \o \r \  \T \a \l \i \g \l \u \c \e \r \a \s \e \space \a \l \f \a \space \( \E \l \e \l \y \s \o \, \space \P \f \i \z \e \r \) \space \a \t \space \i \t \s \  \M \a \r \c \h \space \2 \0 \1 \2 \space \m \e \e \t \i \n \g \. \space \  \T \h \e \space \l \i \s \t \i \n \g " ..."]]

Frequently asked questions have been prepared that outline the transitioning of Herceptin subsidy to the Pharmaceutical Benefits Scheme. These can be ...

The first round of Public Summary Documents (recommendations and subsequent rejections) from the November 2014 PBAC meeting are now in ...

Pharmaceutical companies insist they pay the right amount of tax but have provided few details of the dollars involved ahead of ...

The outcome statements from the February 2015 Drug Utilisation Sub Committee meeting are now available on the PBS website. ...

[:content [\E \i \s \a \i \space \h \a \s \space \s \a \i \d \  \t \h \a \t \space \i \t \space \w \i \l \l \space \t \e \m \p \o \r \a \r \i \l \y \space \s \u \s \p \e \n \d \space \s \a \l \e \s \space \o \f \space \F \y \c \o \m \p \a \space \( \p \e \r \a \m \p \a \n \e \l \) \space \i \n \space \G \e \r \m \a \n \y \space \a \s \space \i \t \space \\ \" \i \s \space \u \n \a \b \l \e \space \t \o \space \a \c \c \e \p \t \space \t \h \e " ..."]]

The February 2015 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. There is only one ...

An update to the Submission Deadlines and Projected Effective Dates, which now includes the application deadlines for all six price change ...

The Schedule of Pharmaceutical Benefits is provided in a variety of formats including PDF versions of both the monthly schedule and ...